The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans

Neuropsychopharmacology

Volumn 24, Issue 5, 2001, Pages 553-560

  Martinez, Diana ^a,b   Gelernter, Joel ^c   Abi Dargham, Anissa ^a,b   Van Dyck, Christopher H ^c   Kegeles, Lawrence ^a,b   Innis, Robert B ^c   Laruelle, Marc ^a,b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b College of Physicians and Surgeons ^*  (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dopamine type 2 receptor; Dopamine uptake transporter; Genotype; Human; Single Photon Emission Tomography; Striatum

Indexed keywords

AMPHETAMINE; COCAINE; DOPAMINE TRANSPORTER;

ADULT; ALLELE; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DNA POLYMORPHISM; DOPAMINE RELEASE; DOPAMINE UPTAKE; DOPAMINERGIC TRANSMISSION; GENOTYPE; HUMAN; PARANOIA; PHENOTYPE; PRIORITY JOURNAL; RNA TRANSLATION; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TANDEM REPEAT;

ADULT; AMPHETAMINE; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BENZAMIDES; CARRIER PROTEINS; COCAINE; COCAINE-RELATED DISORDERS; DOPAMINE; DOPAMINE ANTAGONISTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; GENOTYPE; HUMANS; IODINE RADIOISOTOPES; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MINISATELLITE REPEATS; NEOSTRIATUM; NERVE TISSUE PROTEINS; PHENOTYPE; POLYMORPHISM, GENETIC; PSYCHOTIC DISORDERS; PYRROLIDINES; RADIOPHARMACEUTICALS; SCHIZOPHRENIA; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0035090262     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(00)00216-5     Document Type: Article

References (41)

1. Increased striatal dopamine transmission in schizophrenia: Confirmation in a second cohort
2. Unaltered [3H]GBR-12935 binding after chronic treatment with dopamine active drugs
3. Effects of antipsychotic drugs on dopamine and serotonin contents and metabolites, dopamine and serotonin transporters, and serotonin1A receptors
4. Human dopamine transporter gene not linked to schizophrenia in multigenerational pedigrees
5. A method for attenuation correction in computed tomography
6. Association of attention-deficit disorder and the dopamine transporter gene
7. Mapping susceptibility loci in attention deficit hyperactivity disorder: Preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children
8. Neuropharmacological actions of cigarette smoke: Brain monoamine oxidase B (MAO B) inhibition
9. Brain monoamine oxidase A inhibition in cigarette smokers
10. Population studies of polymorphisms at loci of neuropsychiatric interest (tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), apolipoprotein E (APOE), mu opioid receptor (OPRM1), and ciliary neurotrophic factor (CNTF))
11. Genetic association between dopamine transporter alleles and cocaine-induced paranoia
12. The dopamine transporter protein gene (SLC6A3): Primary linkage mapping, and linkage studies in Tourette's syndrome
13. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism
14. Genotype influences in vivo dopamine transporter availability in human striatum
15. Single photon emission computed tomographic imaging demonstrates loss of striatal transporters in Parkinson's disease
16. Prediction of dopamine transporter binding availability by genotype: A preliminary report
17. Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans
18. Imaging synaptic neurotransmission with in vivo binding competition techniques: A critical review
19. Increased dopamine transmission in schizophrenia: Relationship to illness phases
20. Dopamine and serotonin transporters in patients with schizophrenia: An imaging study with [(123)I]beta-CIT
21. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug free schizophrenic subjects
22. SPECT imaging of striatal dopamine release after amphetamine challenge
23. 123I]β-CIT: Pharmacological characterization of brain uptake in nonhuman primates
24. Evidence suggesting the role of specific genetic factors in cigarette smoking
25. Lack of association between dopamine transporter gene polymorphisms and delusional disorder
26. Dopamine transporter gene polymorphisms are not associated with substance abuse
27. Exclusion of close linkage of the dopamine transporter gene with schizophrenia spectrum disorders
28. Significance of nonuniform attenuation correction in quantitative brain SPECT imaging
29. Neuroleptics and dopamine transporters
30. Brain dopamine transporter: Gender differences and effect of chronic haloperidol
31. A genetic association for cigarette smoking behavior
32. High levels of dopamine activity in the basal ganglia of cigarette smokers
33. Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium
34. PET study of competition between intravenous cocaine and [C-11]raclopride at dopamine receptors in human subjects
35. Modification of alcohol withdrawal by the A9 allele of the dopamine transporter gene
36. 123I]β-CIT SPECT imaging of dopamine and serotonin transporters in tobacco smokers
37. Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons
38. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR
39. Human dopamine transporter gene: Coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations
40. 11C]raclopride in the human brain
41. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: Heterogeneity owing to diagnostic subtype and severity